US equities
|
NVDA
$150.96
▼-2.89%
MU
$705.27
▼-1.00%
AMD
$530.14
▲+5.31%
SPCX
$143.50
▲+1.27%
AAPL
$352.45
▲+0.15%
MSFT
$508.29
▲+0.40%
AMZN
$267.74
▲+3.82%
TSLA
$383.72
▲+0.95%
NVDA
$150.96
▼-2.89%
MU
$705.27
▼-1.00%
AMD
$530.14
▲+5.31%
SPCX
$143.50
▲+1.27%
AAPL
$352.45
▲+0.15%
MSFT
$508.29
▲+0.40%
AMZN
$267.74
▲+3.82%
TSLA
$383.72
▲+0.95%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Krystal Biotech, Inc. - Common Stock
(NQ:
KRYS
)
315.34
+16.79 (+5.62%)
Delayed Quote
Updated: 4:00 PM EST, Nov 18, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Krystal Biotech, Inc. - Common Stock
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Krystal Biotech, Inc. - KRYS
November 17, 2026
From
Pomerantz LLP
Via
GlobeNewswire
Cosmetic Surgery's Next Debate: Rebuild Tissue, Not Fill It
August 11, 2026
News Provided by Biotech Insider on behalf of Conexeu Sciences Inc.
From
Biotech Insider
Via
GlobeNewswire
Krystal Biotech Inc. (NASDAQ: KRYS) is a Leading Gainer in 2/26 Morning Trading
February 26, 2024
Via
Investor Brand Network
Krystal Biotech Inc. (NASDAQ: KRYS) is a Stock Spotlight on 6/8
June 08, 2023
Via
Investor Brand Network
Palvella Therapeutics Strengthens Leadership Team with Appointment of Rare Disease Commercial Leader Jennifer J. McDonough as Senior Vice President of Market Access and Patient Services
March 23, 2026
From
Palvella Therapeutics Inc.
Via
GlobeNewswire
Arbutus Appoints Two New Executives
July 10, 2023
From
Arbutus Biopharma Corporation
Via
GlobeNewswire
Krystal Clear: Krystal Biotech Clears Resistance in Good Volume
May 30, 2023
Regulatory momentum, bullish Wall Street analysts and favorable technicals all suggest Krystal Biotech, Inc. may be a gem.
Via
MarketBeat
Option Care Health Selected by Krystal Biotech as Part of a Limited Distribution Specialty Pharmacy Network for VYJUVEK™
May 23, 2023
From
Option Care Health, Inc.
Via
GlobeNewswire
Krystal Biotech Inc. (NASDAQ: KRYS) Highlighted for Surprising Price Action
May 22, 2023
Via
Investor Brand Network